Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Microba Life Sciences.
RELATED STOCKHEAD STORIES
News
ASX November Winners: Who’s leading the way for small caps as global markets rally?
Health & Biotech
Check Up: The world’s most expensive drug costs $3.5 MILLION a shot – and there’s an Aussie company behind it
News
Rise and Shine: Everything you need to know before the market opens
News
Closing Bell: China calm boosts miners, steadies ASX200 but the silence isn’t all good news
News
ASX Large Caps: Iron ore giants lift ASX as China’s property sector gets a timely boost
News
ASX Small Caps Lunch Wrap: Who else wants to bust up monopolies this morning?
Health & Biotech
ASX Health Stocks: Sonic snaps up stake in Microba, sending MAP share price 60pc higher
News
Top 10 at 10: Which life sciences company just got a big boost from a services giant?
Health & Biotech
ScoPo’s Powerplays: ASX health stocks seek some end of year love
Health & Biotech
ASX Biotech Stocks: Fitbit wants to sell your data to doctors and Wellnex eyes OTC medicinal cannabis product
Health & Biotech
ASX Health Stocks: Race Oncology is set to expand its clinical trial to Spain and Italy
Health & Biotech
ASX Health Stocks: Cynata gets FDA green light for Phase 2, share price up 10pc
Health & Biotech
ASX Health Stocks: Microba is set to enter preclinical assessment as early as this year
Experts
